Part I Radiation Physics |
|
|
|
1 | (4) |
|
A Brief History of Charged Particle Radiotherapy |
|
|
1 | (1) |
|
Heavy Charged Particle Radiotherapy Facilities |
|
|
2 | (3) |
|
Proton Radiotherapy Facilities in Operation |
|
|
2 | (1) |
|
Heavy Charged Particle Facilities in Operation |
|
|
3 | (1) |
|
Facilities under Construction or at the Planning Stage |
|
|
3 | (2) |
|
|
5 | (14) |
|
|
5 | (2) |
|
|
5 | (1) |
|
The Proton's Position in the Hierarchy of Particles |
|
|
5 | (1) |
|
|
5 | (2) |
|
|
7 | (3) |
|
|
8 | (1) |
|
|
8 | (1) |
|
Proton Accelerators Suitable for Radiotherapy |
|
|
9 | (1) |
|
Comparison of Existing Proton Accelerator Types |
|
|
10 | (1) |
|
|
10 | (3) |
|
|
10 | (2) |
|
Shielding of the Beam Transport System |
|
|
12 | (1) |
|
A Future Proton Source for Medical Applications |
|
|
13 | (1) |
|
Summary: Design Criteria for Radiotherapy Proton Beams |
|
|
14 | (5) |
|
|
15 | (1) |
|
Beam Penetration and Precision |
|
|
15 | (1) |
|
Radiation Dose and Dose Rate |
|
|
15 | (1) |
|
|
16 | (1) |
|
|
16 | (3) |
|
Interaction of Protons with Matter |
|
|
19 | (34) |
|
|
19 | (5) |
|
Energy Loss by Excitation and Ionization |
|
|
20 | (2) |
|
Energy Loss by Nuclear Interactions |
|
|
22 | (1) |
|
Elastic Nuclear Interactions |
|
|
22 | (1) |
|
Inelastic Nuclear Interactions |
|
|
22 | (1) |
|
Energy Losses for E ≤ 0.5 MeV |
|
|
22 | (1) |
|
|
23 | (1) |
|
|
24 | (6) |
|
Elastic Coulomb Scattering |
|
|
24 | (1) |
|
|
24 | (1) |
|
|
25 | (2) |
|
Approximations for Moliere's Distribution |
|
|
27 | (1) |
|
Comparison with Experiments |
|
|
28 | (1) |
|
|
29 | (1) |
|
|
30 | (5) |
|
Pathlength, Mean Range and Water Equivalent Ratio |
|
|
30 | (3) |
|
|
33 | (1) |
|
|
34 | (1) |
|
|
35 | (3) |
|
Shape of the Bragg Distribution |
|
|
35 | (2) |
|
Deviations from the Bragg Distribution |
|
|
37 | (1) |
|
Particle Beam Diameter and the Bragg Peak |
|
|
37 | (1) |
|
Influence of Inhomogeneous Media |
|
|
37 | (1) |
|
Protons Penetrating Tissue |
|
|
38 | (5) |
|
Taking Account of Tissue Densities |
|
|
38 | (2) |
|
Tissue Density and CT Number |
|
|
40 | (1) |
|
|
40 | (1) |
|
Accuracy of the CT Numbers |
|
|
40 | (1) |
|
Influence of Edges and Inhomogeneities |
|
|
41 | (1) |
|
|
42 | (1) |
|
|
42 | (1) |
|
Narrow but Long (Thick) Inhomogeneities |
|
|
43 | (1) |
|
Proton Dosimetry and Proton Dose Measurement |
|
|
43 | (7) |
|
|
44 | (1) |
|
|
44 | (1) |
|
|
44 | (1) |
|
Conversion of Ion Dose into Absorbed Radiation Dose |
|
|
44 | (1) |
|
|
45 | (1) |
|
|
45 | (1) |
|
|
46 | (1) |
|
Dose-Volume Histogram (DVH) |
|
|
47 | (1) |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
49 | (1) |
|
|
50 | (1) |
|
|
50 | (1) |
|
Summary and Comparison with Photon Radiotherapy |
|
|
50 | (3) |
|
Modifying the Proton Beam |
|
|
53 | (12) |
|
|
53 | (1) |
|
|
53 | (8) |
|
|
53 | (1) |
|
|
53 | (1) |
|
|
54 | (1) |
|
|
55 | (1) |
|
Longitudinal Beam Shaping |
|
|
55 | (1) |
|
|
55 | (1) |
|
Spread Out Bragg Peak (SOBP) |
|
|
56 | (2) |
|
Generating a Spread Out Bragg Peak |
|
|
58 | (1) |
|
Problems connected with the SOBP |
|
|
59 | (1) |
|
Distal Isodose Shaping Device (DISD) |
|
|
59 | (1) |
|
Beam Shaping and the Penumbra |
|
|
60 | (1) |
|
Dynamic Radiation Field Shaping |
|
|
61 | (4) |
|
|
61 | (1) |
|
|
61 | (1) |
|
|
61 | (1) |
|
|
62 | (1) |
|
Advantages and Disadvantages |
|
|
63 | (1) |
|
|
64 | (1) |
|
Conformal Proton Radiotherapy Planning |
|
|
65 | (28) |
|
|
65 | (4) |
|
The Role of Inhomogeneities |
|
|
65 | (1) |
|
|
66 | (1) |
|
The Influence of Multiple Scattering |
|
|
67 | (2) |
|
|
69 | (14) |
|
|
69 | (1) |
|
|
70 | (1) |
|
|
70 | (1) |
|
|
70 | (1) |
|
Magnetic Resonance Imaging (MRI) |
|
|
71 | (1) |
|
Fusion of Anatomical and Functional Data |
|
|
71 | (1) |
|
|
71 | (1) |
|
|
72 | (1) |
|
|
73 | (1) |
|
|
74 | (2) |
|
|
76 | (1) |
|
Planning for Eye Treatment |
|
|
77 | (1) |
|
|
77 | (1) |
|
|
77 | (2) |
|
Comparison of Treatment Planning Algorithms |
|
|
79 | (1) |
|
Intercomparison of Different Algorithms |
|
|
79 | (1) |
|
Comparison with Simplified Measurements |
|
|
79 | (2) |
|
|
81 | (2) |
|
Overall Accuracy of Treatment Planning and Execution |
|
|
83 | (10) |
|
|
83 | (1) |
|
Factors Influencing Accuracy and Precision |
|
|
83 | (1) |
|
|
83 | (2) |
|
|
85 | (1) |
|
|
85 | (1) |
|
|
86 | (1) |
|
|
86 | (1) |
|
Overall Accuracy of Eye Treatment |
|
|
86 | (1) |
|
|
87 | (6) |
Part II Proton Therapy and Radiotherapy |
|
|
General Aspects of Proton Therapy |
|
|
93 | (16) |
|
General Clinical Overview |
|
|
93 | (16) |
|
|
93 | (1) |
|
|
94 | (1) |
|
|
94 | (1) |
|
History of Non-proton Radiosurgery |
|
|
95 | (1) |
|
Indications for Proton Therapy |
|
|
96 | (1) |
|
Imaging and Planning Requirements |
|
|
96 | (2) |
|
Beam Delivery Requirements |
|
|
98 | (1) |
|
Patient Positioning and Immobilisation |
|
|
98 | (1) |
|
Positioning for Extracranial Lesions |
|
|
99 | (1) |
|
The Composition of Tissues and Proton Therapy Planning |
|
|
99 | (1) |
|
Optimised Proton Beams versus Photon Based Radiosurgery Beams |
|
|
100 | (4) |
|
|
104 | (2) |
|
|
106 | (3) |
|
The Rationale for Proton Therapy |
|
|
109 | (10) |
|
|
109 | (1) |
|
|
109 | (5) |
|
|
111 | (1) |
|
The Inhomogeneity Coefficient and Its Effects |
|
|
111 | (1) |
|
|
112 | (2) |
|
|
114 | (1) |
|
Definition of Radiosurgery and Stereotactic Radiotherapy |
|
|
115 | (1) |
|
Large Field Proton Therapy |
|
|
116 | (1) |
|
|
117 | (1) |
|
|
118 | (1) |
|
|
119 | (26) |
|
Radiobiology for Fractionated Proton Therapy |
|
|
119 | (11) |
|
|
119 | (1) |
|
|
119 | (1) |
|
|
120 | (1) |
|
The Relative Biological Effectiveness |
|
|
121 | (1) |
|
|
122 | (3) |
|
The Importance of Fractionation |
|
|
125 | (1) |
|
The Oxygen Enhancement Ratio - The OER |
|
|
126 | (1) |
|
The Gamma Factor, Malignant Lesions and Fractionated Proton Therapy |
|
|
126 | (1) |
|
Inhomogeneity of Dose and Its Effects |
|
|
127 | (1) |
|
Radiosensitisers/Radioprotectors |
|
|
128 | (1) |
|
|
128 | (1) |
|
|
129 | (1) |
|
The Radiobiology of Single Large Fractions |
|
|
130 | (6) |
|
|
130 | (1) |
|
The Effect of the RBE Variation in the Penumbra of Proton Beams |
|
|
130 | (2) |
|
The Cobalt Gray Equivalent Dose |
|
|
132 | (1) |
|
The Oxygen Enhancement Ratio and radiological effects of Large Single Doses |
|
|
132 | (1) |
|
Inhomogeneity of Dose and Its Effects; the Volume Effect |
|
|
133 | (1) |
|
Fractionated Dose Equivalents to Single Large Doses |
|
|
133 | (1) |
|
Categories of Lesions in the Brain |
|
|
133 | (1) |
|
|
133 | (1) |
|
Meningiomas and Similar Lesions |
|
|
134 | (1) |
|
Low Grade Astrocytoma and Similar Lesions |
|
|
134 | (1) |
|
|
134 | (1) |
|
|
135 | (1) |
|
|
135 | (1) |
|
The Biologically Effective Dose and Fractionation |
|
|
136 | (9) |
|
|
136 | (1) |
|
Notational Convention for the BED |
|
|
136 | (1) |
|
The Linear Quadratic Model of Cell and Tissue Response to Radiation and the BED |
|
|
136 | (1) |
|
Some Commonly Used Values for the α/β Ratio |
|
|
137 | (1) |
|
Inhomogeneity of Dose and the Relative Damage |
|
|
138 | (1) |
|
|
138 | (1) |
|
Optic Nerve and Retinal Tolerance |
|
|
139 | (2) |
|
A Comparison of the Various Dose Levels Used to Treat Uveal Melanoma |
|
|
141 | (1) |
|
Age Related Macular Degeneration |
|
|
141 | (1) |
|
|
142 | (1) |
|
The Dose-Volume Histogram |
|
|
142 | (1) |
|
|
143 | (1) |
|
|
143 | (2) |
|
Dose-Volume Relationships in Proton Therapy and Radiosurgery for Arteriovenous Malformations, Skull Base Meningiomas and Recurrent Malignant Gliomas |
|
|
145 | (18) |
|
|
145 | (1) |
|
Arteriovenous Malformations |
|
|
146 | (5) |
|
Kjelberg's Model for Protons |
|
|
146 | (1) |
|
Dose-volume Observations of Voges et al. (1996) |
|
|
147 | (1) |
|
Flickinger's Models for the Gamma Knife |
|
|
147 | (3) |
|
Dose-volume Analysis of Lax and Karlsson (1996) |
|
|
150 | (1) |
|
Karlsson and Lax et al. (1997) |
|
|
150 | (1) |
|
General Discriminants Influencing Dose-volume Relationships |
|
|
151 | (3) |
|
Illustration of the Effect of the Penumbra and the Prescription Isodose on a Volume of Brain Tissue Constrained to [10 Gy 10 cm3] |
|
|
154 | (1) |
|
Methodology for Calculating the Effects of the Prescription Isodose and Penumbra on the Planning Target Volume Treatable to Safe Doses Within the Constraints of [10 Gy 10 cm3] |
|
|
154 | (3) |
|
The Critical Isodose (CI) |
|
|
154 | (2) |
|
Direct (Computer) Determination of the PTV |
|
|
156 | (1) |
|
Dose-volume Graphs Based on Voges (1996) |
|
|
157 | (1) |
|
Practical Implementation of the Various Dose-volume Relationships Available Presently for AVM Radiosurgery |
|
|
158 | (2) |
|
Recurrent Previously Irradiated Brain Tumours |
|
|
160 | (1) |
|
The Effects of Imperfect Conformation |
|
|
160 | (1) |
|
|
161 | (1) |
|
|
161 | (1) |
|
|
161 | (2) |
|
Low Energy Proton Beam Therapy for Eye Lesions |
|
|
163 | (16) |
|
|
163 | (1) |
|
|
163 | (3) |
|
|
163 | (1) |
|
Age Related Macular Degeneration |
|
|
164 | (2) |
|
Malignant Lesions: Uveal Melanoma |
|
|
166 | (7) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
Results of Proton Therapy |
|
|
167 | (1) |
|
Techniques of Proton Irradiation |
|
|
167 | (4) |
|
Treatment of Uveal Melanoma by Gamma Knife |
|
|
171 | (1) |
|
|
172 | (1) |
|
Metastatic Lesions in the Eye |
|
|
173 | (1) |
|
|
174 | (1) |
|
|
174 | (1) |
|
Retinopathy, Optic Neuropathy, Rubeosis Iridis |
|
|
174 | (1) |
|
Comparison of the Various Dose Levels Used to Treat Uveal Melanoma Using the BED |
|
|
175 | (1) |
|
Tolerance of the Optic Nerve and Retina |
|
|
175 | (1) |
|
|
175 | (1) |
|
|
176 | (3) |
|
High Energy Proton Therapy for Tumours in Body Sites other than the Brain |
|
|
179 | (16) |
|
|
179 | (1) |
|
Co-operative Proton Therapy Groups |
|
|
179 | (1) |
|
The Proton Therapy Co-operative Oncology Group |
|
|
179 | (1) |
|
The Proton Radiation Oncology Group |
|
|
179 | (1) |
|
Protons for Superficial Tumours |
|
|
180 | (4) |
|
|
180 | (1) |
|
|
180 | (1) |
|
Chordomas, Chondromas and Chondrosarcomas |
|
|
181 | (1) |
|
Photon Therapy for Chondromas and Chordomas |
|
|
181 | (1) |
|
|
182 | (1) |
|
Surgery plus Radiotherapy |
|
|
183 | (1) |
|
Esthesioneuroblastoma and Chemo-Proton Radiation |
|
|
184 | (1) |
|
Protons for Deep-Seated Body Tumours |
|
|
184 | (3) |
|
Large Field Therapy with Horizontal Beams |
|
|
184 | (1) |
|
|
184 | (1) |
|
Large Field Therapy with Isocentric Beams |
|
|
185 | (1) |
|
|
185 | (1) |
|
Potential Improvement in the Results of Proton Irradiation for Prostate Cancer |
|
|
186 | (1) |
|
Brachytherapy for Prostate Carcinoma |
|
|
187 | (1) |
|
|
187 | (1) |
|
|
187 | (1) |
|
Potential Gains with Protons in Various Anatomical Sites |
|
|
187 | (4) |
|
|
188 | (1) |
|
Brain Tumours in Children |
|
|
188 | (1) |
|
|
189 | (1) |
|
|
189 | (1) |
|
|
190 | (1) |
|
Retroperitoneal Cancer in a Child with Wilm's Tumour |
|
|
191 | (1) |
|
|
191 | (1) |
|
|
191 | (1) |
|
|
192 | (3) |
|
Radiosurgical Applications of Protons and Photons |
|
|
195 | (50) |
|
|
195 | (20) |
|
|
195 | (1) |
|
Arteriovenous Malformations |
|
|
195 | (1) |
|
Clinical Features of AVMs |
|
|
196 | (1) |
|
Pathology and Prognostic Factors |
|
|
196 | (1) |
|
Evaluation Methods for AVMs |
|
|
197 | (2) |
|
Treatment Options for Ateriovenous Malformations |
|
|
199 | (1) |
|
|
200 | (1) |
|
Proton Radiosurgery for AVMs and Other Methods |
|
|
200 | (1) |
|
|
201 | (1) |
|
|
202 | (1) |
|
Assessing Treatment Outcome - The Scale of Drake |
|
|
202 | (1) |
|
Assessing the Radiological Outcome of Radiosurgery |
|
|
203 | (1) |
|
|
203 | (1) |
|
Post-Treatment Observation, Follow-up and Medication |
|
|
203 | (1) |
|
Radiosurgical Prescription and Dose - CGyE for Proton |
|
|
204 | (1) |
|
Recommended Doses for AVMs |
|
|
204 | (2) |
|
Proton and Helium Ion Bragg Peak Therapy for AVMs |
|
|
206 | (1) |
|
The Obliteration Rate of AVMs with Particles |
|
|
207 | (2) |
|
The Obliteration Rate of AVMs by Gamma Knife and Linear Accelerator |
|
|
209 | (1) |
|
Reducing the Risk of Radionecrosis |
|
|
210 | (1) |
|
Side Effects of Treatment |
|
|
210 | (1) |
|
Causes for Recurrence of AVMs |
|
|
211 | (1) |
|
A Critique on Radiosurgical Techniques |
|
|
211 | (1) |
|
|
212 | (2) |
|
|
214 | (1) |
|
Acoustic and Non-acoustic Neuromas |
|
|
215 | (5) |
|
|
215 | (1) |
|
|
215 | (1) |
|
Radiation and Growth Arrest of Neuromas |
|
|
215 | (1) |
|
Indications for Radiosurgery |
|
|
216 | (1) |
|
Strategies for Hearing Preservation |
|
|
216 | (1) |
|
Complications Other than Hearing Loss with Microsurgery |
|
|
217 | (1) |
|
Clinical Results for Acoustic Neuromas |
|
|
218 | (1) |
|
|
218 | (1) |
|
Gamma Knife and Linear Accelerator |
|
|
218 | (1) |
|
Risk Factors for Complications |
|
|
219 | (1) |
|
Recommended Doses for Acoustic Neuromas |
|
|
219 | (1) |
|
Radiological Changes After Radiosurgery |
|
|
220 | (1) |
|
|
220 | (1) |
|
|
220 | (6) |
|
|
220 | (1) |
|
|
221 | (1) |
|
|
222 | (1) |
|
|
222 | (2) |
|
Complications of Radiosurgery for Meningioma |
|
|
224 | (1) |
|
|
224 | (1) |
|
|
225 | (1) |
|
|
226 | (9) |
|
|
226 | (1) |
|
|
227 | (1) |
|
|
227 | (1) |
|
|
228 | (1) |
|
|
228 | (1) |
|
|
228 | (1) |
|
|
229 | (1) |
|
Conventional Radiation Therapy |
|
|
229 | (1) |
|
Radiosurgery for Pituitary Tumours |
|
|
230 | (1) |
|
Dose Response and Dose-Volume Relationships |
|
|
231 | (1) |
|
|
231 | (2) |
|
|
233 | (1) |
|
|
233 | (1) |
|
|
234 | (1) |
|
Proton and Stereotactic Radiotherapy for Primary and Secondary Brain Tumours |
|
|
235 | (4) |
|
|
235 | (1) |
|
The Importance of Fractionation |
|
|
235 | (1) |
|
Clinical Results Obtained with Primary Malignant Brain Tumours with Radiosurgery |
|
|
236 | (1) |
|
Selection Factors for Glioma Patients and the Hazard Ratio Model for Radiosurgey |
|
|
237 | (1) |
|
Dose Response for Brain Tumours |
|
|
238 | (1) |
|
|
239 | (1) |
|
Secondary Malignant Brain Tumours |
|
|
239 | (3) |
|
Conventional Radiotherapy (Whole Brain) |
|
|
239 | (1) |
|
|
240 | (1) |
|
Radiosurgery for Metastases versus Surgery |
|
|
241 | (1) |
|
Complications of Radiosurgery for Brain Tumours |
|
|
241 | (1) |
|
|
242 | (1) |
|
|
242 | (3) |
|
The Complications of Single Large Intracranial Doses of Radiation and their Management |
|
|
245 | (12) |
|
|
245 | (1) |
|
Classification of Radiation Effects |
|
|
245 | (8) |
|
|
245 | (2) |
|
|
247 | (1) |
|
|
247 | (2) |
|
|
249 | (1) |
|
Vascular Occlusion and Aneurysms |
|
|
250 | (1) |
|
Other Reported Complications |
|
|
251 | (1) |
|
Cranial Nerve Complications |
|
|
251 | (2) |
|
Radiation Induced Complications from Pituitary Lesions, Skull Base Tumours, Uveal Melanoma, Nasopharyngeal Carcinomas and Sarcomas of the Skull Base |
|
|
253 | (1) |
|
Cavernous Sinus Meningiomas |
|
|
253 | (1) |
|
|
253 | (1) |
|
|
253 | (1) |
|
|
254 | (3) |
|
Alternatives to Proton Therapy for Radiosurgery |
|
|
257 | (10) |
|
|
257 | (5) |
|
|
257 | (1) |
|
|
257 | (1) |
|
Versatility and Flexibility |
|
|
258 | (1) |
|
|
258 | (1) |
|
|
258 | (1) |
|
Good Beam Delivery and Planning |
|
|
259 | (1) |
|
Extracranial Radiosurgery |
|
|
259 | (1) |
|
Miniature Multileaf Collimators |
|
|
259 | (1) |
|
|
260 | (1) |
|
Limited Choice of Collimators |
|
|
260 | (1) |
|
|
260 | (1) |
|
The Photon Radiosurgery System |
|
|
261 | (1) |
|
A Comparison of the Fall-off in Dose |
|
|
262 | (1) |
|
Comparative Clinical Results |
|
|
262 | (1) |
|
Large Field Therapy and Alternatives to Protons |
|
|
262 | (1) |
|
|
263 | (1) |
|
|
263 | (1) |
|
|
263 | (1) |
|
|
264 | (3) |
|
Costs of Proton Therapy and Radiosurgery |
|
|
267 | (6) |
|
|
267 | (1) |
|
Patient Fees for Stereotactic Treatment |
|
|
268 | (1) |
|
|
268 | (1) |
|
|
268 | (1) |
|
|
268 | (1) |
|
|
269 | (1) |
|
|
269 | (1) |
|
Life Span of Treatment Units |
|
|
269 | (1) |
|
Cost Comparison: Surgery versus Radiosurgery |
|
|
269 | (1) |
|
|
270 | (1) |
|
|
271 | (2) |
|
|
273 | (12) |
|
The Spetzler Martin Grading System (with Some Remarks) |
|
|
273 | (1) |
|
A Proposed Grading System for AVMs for Radiosurgery |
|
|
274 | (2) |
|
|
276 | (3) |
|
Lateral Dose Fall-off of Various Stationary Radiation Beams |
|
|
279 | (1) |
|
Expanded Tables Based on the Tables of Brenner, Martell and Hall (1991) for Fractionated Therapy for Recurrent Malignant Brain Tumours |
|
|
279 | (1) |
|
Fractionated Treatment for AVMs |
|
|
280 | (1) |
|
The Stereophotogrammetric System of Patient Positioning and Immobilisation |
|
|
281 | (4) |
Subject Index |
|
285 | |